Advanced Historical Cash Flow

AMS Stock   212.50  5.50  2.66%   
Analysis of Advanced Medical cash flow over time is an excellent tool to project Advanced Medical Sol future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Begin Period Cash Flow of 86.4 M or Depreciation of 11.3 M as it is a great indicator of Advanced Medical ability to facilitate future growth, repay debt on time or pay out dividends.
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Advanced Medical Sol latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Advanced Medical Sol is a good buy for the upcoming year.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Advanced Medical Solutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

About Advanced Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in Advanced balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Advanced's non-liquid assets can be easily converted into cash.

Advanced Medical Cash Flow Chart

At present, Advanced Medical's Begin Period Cash Flow is projected to increase significantly based on the last few years of reporting. The current year's Depreciation is expected to grow to about 11.3 M, whereas Change In Cash is projected to grow to (21 M).

Depreciation

Depreciation indicates how much of Advanced Medical Sol value has been used up. For tax purposes Advanced Medical can deduct the cost of the tangible assets it purchases as business expenses. However, Advanced Medical Solutions must depreciate these assets in accordance with IRS rules about how and when the deduction may be taken, and how long it will last. The systematic allocation of the cost of a tangible asset over its useful life.

Capital Expenditures

Capital Expenditures are funds used by Advanced Medical Sol to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Advanced Medical operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.

Stock Based Compensation

Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.

Dividends Paid

The total amount of dividends that a company has paid out to its shareholders over a specific period.
Most accounts from Advanced Medical's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Advanced Medical Sol current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Advanced Medical Solutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
At present, Advanced Medical's Begin Period Cash Flow is projected to increase significantly based on the last few years of reporting. The current year's Depreciation is expected to grow to about 11.3 M, whereas Change In Cash is projected to grow to (21 M).

Advanced Medical cash flow statement Correlations

0.580.180.73-0.71-0.730.29-0.79-0.34-0.51-0.790.77-0.31-0.01-0.25-0.150.540.7
0.580.530.43-0.45-0.540.31-0.540.11-0.02-0.450.720.13-0.220.010.210.760.51
0.180.530.260.240.11-0.12-0.010.710.530.180.370.640.14-0.31-0.090.010.33
0.730.430.26-0.56-0.470.11-0.54-0.38-0.41-0.630.77-0.230.62-0.3-0.230.220.5
-0.71-0.450.24-0.560.85-0.660.850.710.90.95-0.60.650.02-0.1-0.17-0.78-0.42
-0.73-0.540.11-0.470.85-0.570.960.530.690.93-0.720.450.160.190.2-0.71-0.63
0.290.31-0.120.11-0.66-0.57-0.6-0.45-0.6-0.550.13-0.21-0.120.180.410.65-0.01
-0.79-0.54-0.01-0.540.850.96-0.60.520.690.93-0.710.40.080.250.21-0.7-0.62
-0.340.110.71-0.380.710.53-0.450.520.850.67-0.130.71-0.24-0.070.0-0.320.07
-0.51-0.020.53-0.410.90.69-0.60.690.850.85-0.310.79-0.09-0.11-0.09-0.5-0.22
-0.79-0.450.18-0.630.950.93-0.550.930.670.85-0.730.63-0.020.090.11-0.69-0.58
0.770.720.370.77-0.6-0.720.13-0.71-0.13-0.31-0.73-0.240.11-0.27-0.280.510.78
-0.310.130.64-0.230.650.45-0.210.40.710.790.63-0.240.06-0.36-0.03-0.37-0.13
-0.01-0.220.140.620.020.16-0.120.08-0.24-0.09-0.020.110.06-0.33-0.28-0.43-0.13
-0.250.01-0.31-0.3-0.10.190.180.25-0.07-0.110.09-0.27-0.36-0.330.780.31-0.26
-0.150.21-0.09-0.23-0.170.20.410.210.0-0.090.11-0.28-0.03-0.280.780.4-0.3
0.540.760.010.22-0.78-0.710.65-0.7-0.32-0.5-0.690.51-0.37-0.430.310.40.28
0.70.510.330.5-0.42-0.63-0.01-0.620.07-0.22-0.580.78-0.13-0.13-0.26-0.30.28
Click cells to compare fundamentals

Advanced Medical Account Relationship Matchups

Advanced Medical cash flow statement Accounts

201920202021202220232024 (projected)
Change To Inventory(2.5M)(1.9M)941K(7.1M)(8.1M)(7.7M)
Change In Cash(11.6M)(10.9M)19.1M9.3M(22.1M)(21.0M)
Free Cash Flow15.8M16.3M24.6M16.9M4.6M5.8M
Change In Working Capital(4.3M)6.1M1.3M(6.0M)(15.8M)(15.0M)
Begin Period Cash Flow76.4M64.8M53.8M73.0M82.3M86.4M
Other Cashflows From Financing Activities(1.0M)(1.3M)(1.6M)(1.9M)(1.5M)(1.4M)
Depreciation5.8M6.8M8.8M8.8M10.8M11.3M
Other Non Cash Items(5.9M)(3.7M)(4.1M)(3.3M)(1.4M)(1.3M)
Capital Expenditures5.9M5.3M6.5M10.0M9.8M10.3M
Total Cash From Operating Activities21.7M21.5M31.0M26.9M12.3M8.5M
Net Income24.2M10.7M23.0M24.9M15.9M16.7M
Total Cash From Financing Activities(3.6M)(5.8M)(5.1M)(6.3M)(13.3M)(12.6M)
End Period Cash Flow64.8M53.8M73.0M82.3M60.2M63.2M
Stock Based Compensation1.9M1.6M2.0M2.4M2.9M3.1M
Sale Purchase Of Stock(603K)(542K)(366K)(392K)(6.7M)(6.4M)
Dividends Paid3.0M3.3M3.8M4.3M4.8M5.0M
Change To Account Receivables(574K)10.3M(1.8M)(596K)(2.5M)(2.6M)
Investments(29.6M)(26.8M)(6.3M)(11.9M)(20.3M)(21.3M)
Issuance Of Capital Stock1.7M604K1.1M655K181K172.0K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Advanced Stock

The Cash Flow Statement is a financial statement that shows how changes in Advanced balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Advanced's non-liquid assets can be easily converted into cash.